161 related articles for article (PubMed ID: 9547578)
1. PX-52, A novel inhibitor of 14 kDa secretory and 85 kDa cytosolic phospholipases A2.
Franson RC; Rosenthal MD
Adv Exp Med Biol; 1997; 400A():365-73. PubMed ID: 9547578
[TBL] [Abstract][Full Text] [Related]
2. Oligomers of prostaglandin B1 inhibit in vitro phospholipase A2 activity.
Franson RC; Rosenthal MD
Biochim Biophys Acta; 1989 Dec; 1006(3):272-7. PubMed ID: 2597672
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human phospholipases A2 by cis-unsaturated fatty acids and oligomers of prostaglandin B1.
Franson R; Raghupathi R; Fry M; Saal J; Vishwanath B; Ghosh SS; Rosenthal MD
Adv Exp Med Biol; 1990; 279():219-30. PubMed ID: 2129000
[TBL] [Abstract][Full Text] [Related]
4. Oligomers of prostaglandin B1 inhibit arachidonic acid mobilization in human neutrophils and endothelial cells.
Rosenthal MD; Franson RC
Biochim Biophys Acta; 1989 Dec; 1006(3):278-86. PubMed ID: 2557075
[TBL] [Abstract][Full Text] [Related]
5. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
[TBL] [Abstract][Full Text] [Related]
6. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
[TBL] [Abstract][Full Text] [Related]
7. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
8. 5-Lipoxygenase products modulate the activity of the 85-kDa phospholipase A2 in human neutrophils.
Wijkander J; O'Flaherty JT; Nixon AB; Wykle RL
J Biol Chem; 1995 Nov; 270(44):26543-9. PubMed ID: 7592874
[TBL] [Abstract][Full Text] [Related]
9. Activation of cytosolic phospholipase A2 in permeabilized human neutrophils.
Bauldry SA; Wooten RE; Bass DA
Biochim Biophys Acta; 1996 Jan; 1299(2):223-34. PubMed ID: 8555268
[TBL] [Abstract][Full Text] [Related]
10. Role of cytosolic phospholipase A2 in cytokine-stimulated prostaglandin release by human gallbladder cells.
Grossmann EM; Longo WE; Mazuski JE; Panesar N; Kaminski DL
J Gastrointest Surg; 2000; 4(2):193-200. PubMed ID: 10675243
[TBL] [Abstract][Full Text] [Related]
11. Groups I, II and III extracellular phospholipases A2: selective inhibition of group II enzymes by indomethacin but not other NSAIDs.
Lobo IB; Hoult JR
Agents Actions; 1994 Mar; 41(1-2):111-3. PubMed ID: 8079814
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of two biochemically distinct phospholipase A2 activities in human platelet, monocyte, and neutrophil.
Marshall LA; Roshak A
Biochem Cell Biol; 1993; 71(7-8):331-9. PubMed ID: 8123250
[TBL] [Abstract][Full Text] [Related]
13. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
14. The effects of the phospholipase A2 inhibitors aristolochic acid and PGBx on A23187-stimulated mobilization of arachidonate in human neutrophils are overcome by diacylglycerol or phorbol ester.
Rosenthal MD; Lattanzio KS; Franson RC
Biochim Biophys Acta; 1992 Jun; 1126(3):319-26. PubMed ID: 1322178
[TBL] [Abstract][Full Text] [Related]
15. Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2.
Doerfler ME; Weiss J; Clark JD; Elsbach P
J Clin Invest; 1994 Apr; 93(4):1583-91. PubMed ID: 7512985
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phospholipase A2 purified from human herniated disc.
Carabaza A; Cabré F; García AM; Gómez M; Sánchez J; Mauleón D; Carganico G
Biochem Pharmacol; 1993 Feb; 45(3):783-6. PubMed ID: 8442777
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase D is involved in cytosolic phospholipase A2-dependent selective release of arachidonic acid by fMLP-stimulated rat neutrophils.
Fujita K; Murakami M; Yamashita F; Amemiya K; Kudo I
FEBS Lett; 1996 Oct; 395(2-3):293-8. PubMed ID: 8898114
[TBL] [Abstract][Full Text] [Related]
18. Involvement of cytosolic phospholipase A2 and secretory phospholipase A2 in arachidonic acid release from human neutrophils.
Marshall J; Krump E; Lindsay T; Downey G; Ford DA; Zhu P; Walker P; Rubin B
J Immunol; 2000 Feb; 164(4):2084-91. PubMed ID: 10657662
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of calcium-dependent phospholipase A2 activity in membrane preparation of rabbit neutrophils. Absence of activation by fMet-Leu-Phe, phorbol 12-myristate 13-acetate and A-kinase.
Matsumoto T; Tao W; Sha'afi RI
Biochem J; 1988 Mar; 250(2):343-8. PubMed ID: 3128281
[TBL] [Abstract][Full Text] [Related]
20. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):825-31. PubMed ID: 8387780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
